Financings in Brief: Female Health Co.
This article was originally published in The Gray Sheet
Female Health Co.: Raises $2 mil. through the private placement of 729,927 shares of convertible preferred stock at $2.74 each and four-year warrants to purchase 240,000 shares of common stock. The Chicago-based maker of female condoms plans to use the proceeds for general working capital purposes. The warrants are "exercisable at a price per share equal to the lesser of $3.425 or the average of the three closing bid prices per share of common stock for any three consecutive trading days chosen by the investor during the 30 trading day period ending on the trading day immediately prior to the exercise of the warrants," the company explains. Shoreline Pacific was placement agent for the offering...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.